Research across Kidney Diseases
Related studies from across the Kidney Diseases family.
6 trials tracked for Chronic Kidney Disease Stage 5: 3 in phase 3 or 4 and 1 with published results. The most-cited published study has 3 citations.
Showing the 6 most-cited and recently-updated of 6 trials. Browse the full registry →
Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.
Clinical investigations into mineral management in CKD Stage 5 include the use of Fosrenol (Lanthanum Carbonate). In a Phase 3 trial, administration of Fosrenol resulted in statistically significant changes in serum calcium levels at 4 weeks (p=0.0249) 3. However, the change from baseline in serum phosphorus levels at 4 weeks did not reach statistical significance (p=0.1130) 3.
Evaluations of Zemplar® injection for mineral management showed no statistically significant difference in calcium absorption fractions when analyzed by ANOVA (p=0.573) or Mixed Model (p=0.670) 2. Telavancin has also been evaluated in a Phase 4 study for this population 1.
AI synthesis of 6 cited trials, updated Jun 29, 2026. Informational only — not medical advice; trial data sourced from ClinicalTrials.gov. How we use AI.
Related studies from across the Kidney Diseases family.